Sars-Co2 Antibody Test

NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test)
UNCOV-40 40 Tests
EUR 115

Human IgG antibody Laboratories manufactures the sars-co2 antibody test reagents distributed by Genprice. The Sars-Co2 Antibody Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Sars-Co2 products are available in stock. Specificity: Sars-Co2 Category: Antibody Group: Test

EM (Anti-endometrial Antibody IgG) ELISA test
96T/Box Ask for price
Description: ELISA based test for quantitative detection of EM (Anti-endometrial Antibody IgG)

ASA (Anti-sperm Antibody IgG) ELISA test
96T/Box Ask for price
Description: ELISA based test for quantitative detection of ASA (Anti-sperm Antibody IgG)

Mg (Mycoplasma Genitalium Antibody IgG) ELISA test
96T/Box Ask for price
Description: ELISA based test for quantitative detection of Mg (Mycoplasma Genitalium Antibody IgG)

Mh (Mycoplasma Hominis Antibody IgG) ELISA test
96T/Box Ask for price
Description: ELISA based test for quantitative detection of Mh (Mycoplasma Hominis Antibody IgG)

Ct (Chlamydia Trachomatis Antibody IgG) ELISA test
96T/Box Ask for price
Description: ELISA based test for quantitative detection of Ct (Chlamydia Trachomatis Antibody IgG)

MV (Measles Virus Antibody IgG) ELISA test
96T/Box Ask for price
Description: ELISA based test for quantitative detection of MV (Measles Virus Antibody IgG)

TB (Mycobacterium Tuberculosis Antibody IgG) ELISA test
96T/Box Ask for price
Description: ELISA based test for quantitative detection of TB (Mycobacterium Tuberculosis Antibody IgG)

Test information

SARS Spike Antibody
24218-100ul 100ul
EUR 468

SARS Spike Antibody
24219-100ul 100ul
EUR 468

SARS Spike Antibody
24318-100ul 100ul
EUR 468

SARS Spike Antibody
20-abx137184
  • EUR 1262.40
  • EUR 1846.80
  • EUR 2064.00
  • 100 ug
  • 200 ug
  • 300 µg

SARS Spike Antibody
20-abx137200
  • EUR 1412.40
  • EUR 2264.40
  • EUR 2665.20
  • 100 ug
  • 200 ug
  • 300 µg

SARS Matrix Antibody
24319-100ul 100ul
EUR 468

SARS Matrix Antibody
24320-100ul 100ul
EUR 468

SARS Envelope Antibody
24321-100ul 100ul
EUR 468

SARS Envelope Antibody
24322-100ul 100ul
EUR 468

GENLISA™ SARS-CoV-2 (Covid-19) Surrogate Virus Neutralization Test (sVNT) ELISA
KBVH400 12 × 8 wells
EUR 3822

PLPro Antibody (SARS-CoV)
100863 250 µg
EUR 360
Description: Chicken polyclonal antibody recognizing the SARS-CoV Papain-like Protease (PLpro) as a 35 kDa protein. Purified from egg yolks. This antibody recognizes PLPro from both SARS-CoV-1 and SARS-CoV-2. Does not cross react with SARS-CoV 3CL protease.

SARS-CoV Spike Antibody
3225-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3225-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3219-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3219-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.